liraglutide glp 1 agonist FDA Approves Generic Version of Injection, a GLP-1 for Weight Loss GLP-1 Agonists Show Promise in

69% have been using the medication for fewer than two years and 53% expect to discontinue use in less than two more years 77% who had discontinued a GLP-1 medication said they were satisfied with the weight loss they experienced, but 90% were on the drug for less than one year Primary barriers to continued use: 76% note side effects

This finding suggests that DPP4 inhibitors, owing to their GLP-1-enhancing actions, may have a direct beneficial effect on cardiomyocyte function

How long does it take to see weight loss results

Similar content being viewed by others Introduction Weight regain (WR) and insufficient weight loss (IWL) are significant challenges faced by 2025% of patients following bariatric surgery, often stemming from a combination of anatomical variations, genetic predispositions, hormonal imbalances, dietary noncompliance, and inadequate physical activity [1,2,3]

No need to remain on drugs indefinitely (with their side effects, cost, and adherence challenges) if surgery is successful

Sometimes people are more responsive to one hormone or another and having a variety of options available would allow a greater number of treatment options. Mir Ali, MD The next step would be to compare the effectiveness of this new medication with ones already on the market and compare cost, Ali added